Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: A placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)

Robyn P.M. Saw, Bruce K. Armstrong, Rebecca S. Mason, Rachael L. Morton, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: A placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science